Eli Lilly and Company & United States — Food and Drug Administration
7 shared events · Importance 3 · Last updated Apr 13, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Domestic
Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.
United States — Food and Drug Administration: The United States — Food and Drug Administration approved Eli Lilly and Company's weight loss pill, Foundayo, impacting the pharmaceutical market.
Apr 01, 2026 · 14 articles
Business
Eli Lilly and Company: Eli Lilly and Company is a key competitor to Novo Nordisk in the obesity drug market, with its drug Zepbound surpassing Wegovy in US prescriptions, contributing to Novo Nordisk's market challenges.
May 16, 2025 · 7 articles
Business
Eli Lilly and Company: Eli Lilly and Company faces increased competition with Novo Nordisk's Wegovy pill launch, potentially impacting its market dominance in weight-loss drugs. Its shares fell following the announcement.
Jan 05, 2026 · 7 articles
NEWSDESK
Explore this relationship live
Track how Eli Lilly and Company and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.
Open Dashboard